STAGE IV SOFT TISSUE SARCOMA AJCC V7
Clinical trials for STAGE IV SOFT TISSUE SARCOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV SOFT TISSUE SARCOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV SOFT TISSUE SARCOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough sarcomas: adding a targeted drug to standard treatment
Disease control OngoingThis study is for patients with newly diagnosed, high-risk soft tissue sarcomas that can be removed by surgery. It tests whether adding a drug called pazopanib to standard pre-surgery treatments (radiation with or without chemotherapy) helps shrink tumors more effectively and imp…
Matched conditions: STAGE IV SOFT TISSUE SARCOMA AJCC V7
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New hope for kids with tough cancers: treatment guided by tumor genetics
Disease control OngoingThis study is testing a personalized approach for children and young adults with advanced cancers that have come back or stopped responding to standard treatments. Doctors first test the genetic makeup of a patient's tumor to look for specific changes. If a matching change is fou…
Matched conditions: STAGE IV SOFT TISSUE SARCOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC